An official who oversees a team at the Food and Drug Administration that reviews Neuralink Corp. devices was fired, according to an email the agency sent to staff Tuesday morning viewed by Bloomberg.
Apple's ecosystem, premium positioning, and focus on privacy are driving its dominance in health tech, poised to disrupt ...
Scott Whitaker sent a letter to the HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S. leadership in medtech are on the line.
Straumann is in fine financial health. The firm has a healthy balance sheet and it has been averse to taking on any significant debt. It has held a debt/EBITDA below 1, on average, over the past 10 ...
As the dust settles from the first wave of firings at health agencies, here's how many people got cut, and the impact of the ...
As the dust settles from the first wave of firings at health agencies, here's how many people got cut and the impact of the ...
Home healthcare is evolving significantly because of tele?he?alth adva?nced medical equipment and empowering patients in ...
From artificial intelligence to developments in robotic surgery, technology continues to reshape the ASC industry in new and dynamic ways.
Expert sommeliers can take a whiff of a glass of wine and tell you a lot about what's in your pinot noir or cabernet sauvignon.A team of physicists at ...
We recently published a list of the 10 Best Performing Healthcare Stocks So Far in 2025. In this article, we are going to ...
The drug fenfluramine has been recommended by the National Institute for Health and Care Excellence (NICE) for children with a rare form of epilepsy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results